Literature DB >> 27401447

Melanoma in Mexico: Clinicopathologic Features in a Population with Predominance of Acral Lentiginous Subtype.

Leonardo S Lino-Silva1, Jorge A Domínguez-Rodríguez2, José M Aguilar-Romero3, Héctor Martínez-Said3, Rosa A Salcedo-Hernández3, Leticia García-Pérez4, Ángel Herrera-Gómez3, Mario Cuellar-Hubbe3.   

Abstract

BACKGROUND: The aim of this study was to analyze the clinicopathologic features of melanoma in México as the demographics of melanoma are not well known in Mexican and Latin American people.
MATERIALS AND METHODS: A total of 1219 patients with cutaneous melanoma were analyzed through a retrospective database collected from a cancer referral institute, and the results were compared with developed countries.
RESULTS: Median age was 57 years, and 713 (58.5 %) were females. The most common melanoma subtype was acral lentiginous melanoma (ALM), which was observed in 538 (44.1 %) patients. Median Breslow thickness was 5.2 mm. Among 837 patients with complete data, the 5-year disease-specific survival (DSS) was 52.3 %. Factors associated with worse DSS on univariate analysis were Breslow thickness (p < 0.001), recurrence (p < 0.001), ulceration (p < 0.001), positive margin (p < 0.001), ALM (p = 0.001), and male sex (p = 0.001). Multivariate analysis demonstrated Breslow thickness [hazard ratio (HR) 1.45, 95 % confidence interval (CI) 1.27-1.65; p < 0.001], positive margin (HR 1.25, 95 % CI 1.03-1.57; p = 0.018), recurrence (HR 9.56, 95 % CI 6.89-9.87; p = 0.002), ALM (HR 8.07, 95 % CI 6.77-8.95; p = 0.004), and male sex (HR 1.33, 95 % CI 1.06-1.68; p = 0.013) as independent risk factors for DSS.
CONCLUSION: Our patients had worse prognosis compared with data from the US Surveillance, Epidemiology, and End Results database. We found male sex and ALM as independent risk factors for worse survival, in addition to known risk factors.

Entities:  

Mesh:

Year:  2016        PMID: 27401447     DOI: 10.1245/s10434-016-5394-x

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  9 in total

Review 1.  The World of Melanoma: Epidemiologic, Genetic, and Anatomic Differences of Melanoma Across the Globe.

Authors:  Florentia Dimitriou; Regina Krattinger; Egle Ramelyte; Marjam J Barysch; Sara Micaletto; Reinhard Dummer; Simone M Goldinger
Journal:  Curr Oncol Rep       Date:  2018-09-24       Impact factor: 5.075

2.  Tumor infiltrating lymphocytes in acral lentiginous melanoma: a study of a large cohort of cases from Latin America.

Authors:  C A Castaneda; C Torres-Cabala; M Castillo; V Villegas; S Casavilca; L Cano; J Sanchez; J Dunstan; G Calderon; M De La Cruz; J M Cotrina; H L Gomez; R Galvez; J Abugattas
Journal:  Clin Transl Oncol       Date:  2017-06-02       Impact factor: 3.405

3.  Melanoma: a global perspective.

Authors:  Raul Ossio; Rodrigo Roldán-Marín; Héctor Martínez-Said; David J Adams; Carla Daniela Robles-Espinoza
Journal:  Nat Rev Cancer       Date:  2017-04-28       Impact factor: 60.716

4.  Complete spontaneous regression of a metastatic acral melanoma with associated leukoderma.

Authors:  Isobel R Spring; Johann de Wet; Henry Francois Jordaan; Bianca Tod; Willem I Visser
Journal:  JAAD Case Rep       Date:  2017-11-06

Review 5.  Melanoma subtypes: genomic profiles, prognostic molecular markers and therapeutic possibilities.

Authors:  Roy Rabbie; Peter Ferguson; Christian Molina-Aguilar; David J Adams; Carla D Robles-Espinoza
Journal:  J Pathol       Date:  2019-02-15       Impact factor: 7.996

6.  The Clinicopathological and Survival Profiles Comparison Across Primary Sites in Acral Melanoma.

Authors:  Xiaoting Wei; Di Wu; Hang Li; Rui Zhang; Yu Chen; Hong Yao; Zhihong Chi; Xinan Sheng; Chuanliang Cui; Xue Bai; Zhonghui Qi; Ke Li; Shijie Lan; Lizhu Chen; Rui Guo; Xinyu Yao; Lili Mao; Bin Lian; Yan Kong; Jie Dai; Bixia Tang; Xieqiao Yan; Xuan Wang; Siming Li; Li Zhou; Charles M Balch; Lu Si; Jun Guo
Journal:  Ann Surg Oncol       Date:  2020-04-06       Impact factor: 5.344

7.  The influence of body mass index on the survival of patients with melanoma. A cross-sectional study of 707 patients.

Authors:  Cesar Zepeda-Najar; Leonardo Saul Lino-Silva; Jazmin D Chávez-Hernandez; Rosa A Salcedo-Hernández; Johana P Jimenez-Sánchez; Carlos E Fernández-Sánchez; Carlos D Valdez-Aguilar
Journal:  Contemp Oncol (Pozn)       Date:  2021-03-24

8.  Cutaneous melanoma incidence, mortality, and survival in Manizales, Colombia: a population-based study.

Authors:  Juan David Rodríguez-Betancourt; Nelson Arias-Ortiz
Journal:  J Int Med Res       Date:  2022-06       Impact factor: 1.573

Review 9.  Acral lentiginous melanoma: Basic facts, biological characteristics and research perspectives of an understudied disease.

Authors:  Patricia Basurto-Lozada; Christian Molina-Aguilar; Carolina Castaneda-Garcia; Martha Estefania Vázquez-Cruz; Omar Isaac Garcia-Salinas; Alethia Álvarez-Cano; Héctor Martínez-Said; Rodrigo Roldán-Marín; David J Adams; Patricia A Possik; Carla Daniela Robles-Espinoza
Journal:  Pigment Cell Melanoma Res       Date:  2020-06-17       Impact factor: 4.693

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.